Bone studies in patients on prolonged systemic corticosteroid therapy for asthma

Paul Allen Greenberger*, Ronald W Hendrix, R. PATTERSON, Joan S Chmiel

*Corresponding author for this work

Research output: Contribution to journalArticle

22 Scopus citations


Cortical thickness of the second metacarpal bone and lumbar spine fractures were determined radiographically in twenty‐one Caucasian corticosteroid‐dependent asthmatics (mean age, 61‐2 years; range 47‐73 years). The mean number of prednisone years per patient of continuous corticosteroid treatment averages 9.7 (range 5.0‐21.5 years), and the mean accumulated dose of prednisone was 46.7 g (range 10.7‐160 g). Thirteen of twenty‐one (61.9%) patients had cortical thickness between 1 and 2 standard deviations (s.d.) below the age‐ and sex‐specific mean for normals, but only four (19%) patients fell below 2 s.d. Although the study indicated decreased cortical thickness in the prednisone‐treated group, in only one (4.8%) patient were vertebral fractures present, an incidence not unexpected in this age group. In serious chronic asthma, concern for bone structure should not prohibit the cautious use of appropriate corticosteroid regimens at the lowest possible maintenance dose.

Original languageEnglish (US)
Pages (from-to)363-368
Number of pages6
JournalClinical & Experimental Allergy
Issue number4
StatePublished - Jan 1 1982

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Bone studies in patients on prolonged systemic corticosteroid therapy for asthma'. Together they form a unique fingerprint.

  • Cite this